Showing results (51-60 of 361) with videos related to
Sort By:
Pageof 37
Molecular and Cellular Biology|July 8, 2009
Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancerCallinice D Capo-chichi, Kathy Q Cai, Joseph R Testa, et al.Nature Biomedical Engineering|May 25, 2019
Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chipPeng Zhang, Xin Zhou, Mei He, et al.Cancer Research|April 12, 2011
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancerMary E Urick, Meghan L Rudd, Andrew K Godwin, et al.BMC Cancer|February 10, 2025
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine modelVijayalaxmi G Gupta, Katherine F Roby, Harsh B Pathak, et al.ACS Applied Bio Materials|November 1, 2024
Tracking Small Extracellular Vesicles Using a Minimally Invasive PicoGreen Labeling StrategySagar Rayamajhi, Benjamin K Gibbs, Jared Sipes, et al.Cancer Research|November 12, 2009
Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic dataMichael F Ochs, Lori Rink, Chi Tarn, et al.Human Pathology|November 20, 2016
Role of miR-139 as a surrogate marker for tumor aggression in breast cancerHongyan Dai, Dan Gallagher, Sarah Schmitt, et al.International Journal of Laboratory Hematology|September 29, 2021
Comparison of flow cytometry and next-generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute's practical clinical experiencePaul F McGowan, Stephen D Hyter, Wei Cui, et al.Scientific Reports|June 20, 2020
WNT and inflammatory signaling distinguish human Fallopian tube epithelial cell populationsIan M Rose, Mallikarjun Bidarimath, Alex Webster, et al.Cytotherapy|June 30, 2025
Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trialsMeizhang Li, Rupal Soder, Sunil Abhyankar, et al.Pageof 37